Senior Capitol Hill staffers expect to see an increase in lobbying on issues related to pharmaceutical and health products this year, our latest survey found.
Become a Premium member to continue reading
Become a MemberAlready a subscriber? Log In
Senior Capitol Hill staffers expect to see an increase in lobbying on issues related to pharmaceutical and health products this year, our latest survey found.